|
Contraception with levonorgestrel system and risks of breast cancer.
|
Alouini S, Venslauskaite G, Lubarskiene Z
|
American journal of obstetrics and gynecology. 2015 Feb; 212(Feb):255. doi: 10.1016/j.ajog.2014.10.1100. pii: S0002-9378(14)02192-9.
|
|
How can information on the risk of breast cancer and hormone therapy be better understood?
|
Machado R B, Santana N, Arruda L F, Reggi N, Gandolpho A C, Siani de Moraes S
|
Climacteric : the journal of the International Menopause Society. 2015 ; 18():545-50. doi: 10.3109/13697137.2015.1015513. pii: .
|
|
Is breast cancer risk the same for all progestogens?
|
Stute Petra
|
Archives of gynecology and obstetrics. 2014 Aug; 290(Aug):207-9. doi: 10.1007/s00404-014-3270-0. pii: .
|
|
Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
|
Iversen Lisa, Sivasubramaniam Selvaraj, Lee Amanda J, Fielding Shona, Hannaford Philip C
|
American journal of obstetrics and gynecology. 2017 06; 216(06):580.e1-580.e9. doi: 10.1016/j.ajog.2017.02.002. pii: S0002-9378(17)30179-5.
|
|
Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
|
Kool M, Fontein D B Y, Meershoek-Klein Kranenbarg E, Nortier J W R, Rutgers E J T, Marang-van de Mheen P J, van de Velde C J H
|
Breast (Edinburgh, Scotland). 2015 Jun; 24(Jun):224-9. doi: 10.1016/j.breast.2015.01.010. pii: S0960-9776(15)00011-9.
|
|
Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
|
Jones Michael E, Schoemaker Minouk J, Wright Lauren, McFadden Emily, Griffin James, Thomas Dawn, Hemming Jane, Wright Karen, Ashworth Alan, Swerdlow Anthony J
|
British journal of cancer. 2016 08; 115(08):607-15. doi: 10.1038/bjc.2016.231. pii: .
|
|
Position of the Spanish Menopause Society regarding the management of menopausal symptoms in breast cancer patients.
|
Sánchez-Borrego Rafael, Mendoza Nicolás, Beltrán Estanislao, Comino Rafael, Allué Josep, Castelo-Branco Camil, Cornellana Maria Jesús, Duran Magda, Haya Javier, Juliá Maria Dolores, Llaneza Plácido, Navarro Maria Concepción, Quereda Francisco
|
Maturitas. 2013 Jul; 75(Jul):294-300. doi: 10.1016/j.maturitas.2013.04.016. pii: S0378-5122(13)00127-8.
|
|
Position of the Spanish Menopause Society regarding the management of perimenopause.
|
Mendoza N, Sánchez-Borrego R, Cancelo M J, Calvo A, Checa M A, Cortés J, Elorriaga M A, Díaz T, González J V, Lete I, Lobo P, Martínez-Astorquiza T, Nieto A, Olalla M A, Pérez-Campos E, Porqueras R, Quereda F, Salamanca A, De La Viuda E,
|
Maturitas. 2013 Mar; 74(Mar):283-90. doi: 10.1016/j.maturitas.2012.12.010. pii: S0378-5122(12)00410-0.
|
|
Progestin and breast cancer risk: a systematic review.
|
Samson Marsha, Porter Nancy, Orekoya Olubunmi, Hebert James R, Adams Swann Arp, Bennett Charles L, Steck Susan E
|
Breast cancer research and treatment. 2016 Jan; 155(Jan):3-12. doi: 10.1007/s10549-015-3663-1. pii: .
|
|
Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.
|
Davidson Brittany Anne, Moorman Patricia G
|
Expert opinion on drug safety. 2014 Oct; 13(Oct):1375-82. doi: 10.1517/14740338.2014.951327. pii: .
|
|
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.
|
Zhao Shanshan, Chlebowski Rowan T, Anderson Garnet L, Kuller Lewis H, Manson JoAnn E, Gass Margery, Patterson Ruth, Rohan Thomas E, Lane Dorothy S, Beresford Shirley Aa, Lavasani Sayeh, Rossouw Jacques E, Prentice Ross L
|
Breast cancer research : BCR. 2014 Mar; 16(Mar):R30. doi: 10.1186/bcr3632. pii: .
|
|
Sex hormones and breast cancer risk and prognosis.
|
Folkerd Elizabeth, Dowsett Mitch
|
Breast (Edinburgh, Scotland). 2013 Aug; 22 Suppl 2(Aug):S38-43. doi: 10.1016/j.breast.2013.07.007. pii: S0960-9776(13)00142-2.
|